Case report vancomycin -resistant Enterococcus faecium VanA phenotype: first documented isolation in India

Srujana Mohanty1, Benu Dhawan, R S Gadepalli

  • 1Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

Insights

Vancomycin-resistant Enterococcus faecium (VRE) infections pose a significant threat. This case highlights a fatal VRE sepsis in a child in India, emphasizing the urgent need for infection control.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pediatrics

Background:

  • Vancomycin-resistant enterococci (VRE), particularly Enterococcus faecium, are significant nosocomial pathogens.
  • VRE poses a serious threat to patients with compromised immune systems.

Observation:

  • A 3-year-old child with a patent ductus arteriosus developed a central venous catheter-related infection.
  • The infection was caused by vancomycin-resistant Enterococcus faecium (VRE) with a high-level vancomycin resistance (MIC > or = 256 microg/ml).
  • The VRE isolate was also resistant to teicoplanin, exhibiting the VanA phenotype.

Findings:

  • This represents the first reported isolation of VanA phenotype Enterococcus faecium in India.
  • The child likely succumbed to sepsis caused by this highly resistant VRE strain.

Implications:

  • This case underscores the critical need for enhanced surveillance and infection control measures for VRE in healthcare settings, especially in pediatric populations.
  • The emergence of highly resistant VRE strains necessitates the development of alternative therapeutic strategies and rapid diagnostic methods.
  • Further research is crucial to understand the epidemiology and transmission dynamics of VRE in India.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...